Clinical Trials Logo

Clinical Trial Summary

Gastric outlet obstruction (GOO) occurs commonly in malignancies involving the periampullary region (cancers originating in the head of the pancreas, duodenum, bile duct, or ampulla) or the distal stomach. GOO not only causes debilitating symptoms such as nausea, vomiting, inability to tolerate oral intake, and prevents adequate nutritional intake. Therefore, providing therapy for GOO is imperative to improve the quality of life, and nutritional status of these patients, as well as allow them to continue receiving their cancer treatment


Clinical Trial Description

After potential subjects are screened from the physicians' schedules, they will be assessed for further inclusion criteria. They will be presented with the informed consent form for their review. Once they have been given the opportunity to review and ask questions, they will sign the consent form and from this point will be considered enrolled into the study. After signing the informed consent, subjects will be randomized to one of the two cohorts in a 1:1 manner. On the day of their assigned procedures, subjects will be asked several quality of life questionnaires to obtain a baseline status. Data will be collected during and immediately following the procedure to assess for any possible adverse events. Follow-up data will be completed at the following timepoints: 1-day, 2-day, 3-day, 4-day, and 7-day, 30-day, 3-month, 6-month, and 1-year post-procedure. QOL Scoring Systems GOOSS- Gastric Outlet Obstruction Symptom Score - 1 Inadequate or no oral intake - 2 Liquids/thickened liquids - 3 Semisolids/ low residue - 4 unmodified GFS- Gut Function Score from Lowe et al 2002 - 0 Profuse vomiting - 1 Nausea and occasional vomiting - 2 Nausea only - 3 Normal gut function Pre-Procedure Variables to Record Demographic - Gender - Weight - BMI - Cancer Type Clinical Parameters - GOOSS - Gut Function Score - Karnofsky Performance Scale Procedural Parameters - EUS-GJ: presence of ascites, able to pass scope beyond obstruction, use of wire to stabilize position, Length of procedure, intraprocedural AEs, Stent size used, successful completion of procedure - Laparoscopic GJ: presence of ascites, length of procedure, intraprocedural AEs, conversion to open GJ, successful completion of procedure Post-procedure Hospitalization Daily Function - GOOSS - Gut Function Score - Time to initiation of oral intake liquids - Time to initiation of oral intake solids - Time to discharge - Post procedural AEs 30 Day Outcomes - GOOSS - Gut Function Score - Karnofsky Performance Scale - Weight/BMI - Able to tolerate TB approved chemotherapeutic regimen ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05561907
Study type Interventional
Source Northwell Health
Contact Molly Stewart
Phone 718-470-4667
Email mstewart8@northwell.edu
Status Recruiting
Phase N/A
Start date October 28, 2022
Completion date June 2025

See also
  Status Clinical Trial Phase
Recruiting NCT05548114 - Randomized Trial of EUS-guided Gastrojejunostomy and Surgical Gastrojejunostomy in Gastric Outlet Obstruction N/A
Recruiting NCT03259763 - EUS-GE vs ES for Palliation of Gastric Outlet Obstruction N/A
Not yet recruiting NCT05605327 - EUS-guided Versus Laparoscopic Gastrojejunostomy for Malignant Gastric Outlet Obstruction N/A
Completed NCT02299258 - Gastric Outlet Obstructions Tailored Covered Stents for GOO N/A
Not yet recruiting NCT06174805 - AXIOS™ Gastroenterostomy for Gastric Outlet Obstruction IDE N/A
Recruiting NCT05640947 - Endoscopic Ultrasound-guided Large Diameter Lumen-apposing Metal Stent Gastro-gastrostomy for Bypass Reversal in Patients With Roux-en-y Gastric Bypass N/A
Terminated NCT00487552 - Magnetic Anastomosis Device Relief of Malignant Gastric Outlet Obstruction Phase 1
Completed NCT00556283 - RCT: STARR vs Biofeedback Phase 4
Enrolling by invitation NCT05041608 - Endoscopic Surgery for Gastrointestinal Disorders: A Multicenter Registry Study
Completed NCT03823690 - EPASS Versus Uncovered Duodenal Stent for Unresectable Malignant Gastric Outlet Obstruction. N/A
Recruiting NCT05644951 - Clinical Trial of EPASS With Hot AXIOS System N/A
Completed NCT00991614 - EVOLUTION® Duodenal Stent for Duodenal or Gastric Outlet Obstruction Caused by Malignant Neoplasms N/A
Recruiting NCT04813055 - Prospective Registry Of Therapeutic EndoscopiC ulTrasound
Completed NCT03223480 - EUS - Guided Balloon-occluded Gastrojejunostomy Bypass Phase 2/Phase 3
Completed NCT04660695 - Nasobiliary Drain Assisted EUS-guided Gastroenterostomies in Unresectable Malignant Gastric Outlet Obstruction
Completed NCT01839292 - ComVi and D-type Stent in Malignant GOO N/A
Recruiting NCT06071507 - Management of Malignant Gastric Outlet Obstruction Between Surgery and Endoscopy